Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CGC
CGC logo

CGC Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
1.140
Open
1.130
VWAP
1.12
Vol
4.53M
Mkt Cap
497.59M
Low
1.110
Amount
5.08M
EV/EBITDA(TTM)
232.49
Total Shares
448.28M
EV
600.99M
EV/OCF(TTM)
--
P/S(TTM)
1.34
Canopy Growth Corporation is a cannabis company, which produces, distributes, and sells a diverse range of cannabis and cannabis-related products for both adult-use and medical purposes. The Company brands include tweed, DOJA, LivRelief Infused, Deep Space, Ace Valley, 7ACRES, Vert, Twd, Wana, Hiway and Canopy Medical. The LivRelief Infused is transdermal creams contain a delivery system designed to penetrate a range of cannabidiol (CBD) and tetrahydrocannabinol (THC). The Deep Space offers beverages and gummies, containing the THC potency available in the Canadian market. The Ace Valley is a cannabis brand focused on ready-to-enjoy beverages. The 7ACRES offers products that are crafted by cannabis enthusiasts. The Wana gummies are created with a handcrafted recipe made with pectin, not gelatin, creating a gluten-free shelf-stable recipe that doesn’t melt. Its Canopy Medical is a pharmaceutical manufacturer for the production, import and release of medical cannabis products in Germany.
Show More

Events Timeline

(ET)
2026-05-07
08:00:00
Canopy Growth Expands Minor Cannabinoid Softgel Lineup
select
2026-04-23 (ET)
2026-04-23
13:10:00
Roth Capital: Cannabis Products Rescheduled to Schedule 3
select
2026-04-23
10:30:00
Trump Orders Medical Marijuana Products to Schedule III
select
2026-04-23
10:00:00
Trump Signs Order to Reschedule Medical Marijuana to Schedule III
select
link
2026-04-22 (ET)
2026-04-22
12:00:00
Trump Administration Expected to Reclassify Cannabis on Wednesday
select
link
2026-04-10 (ET)
2026-04-10
08:50:00
Significant Increases in Borrow Rates Among Liquid Option Names
select
2026-04-08 (ET)
2026-04-08
08:50:00
Significant Increases in Indicative Borrow Rates for Liquid Options
select
2026-03-31 (ET)
2026-03-31
07:40:00
Canopy Growth Launches New Cannabis Brand Deelish
select
2026-03-27 (ET)
2026-03-27
07:40:00
Canopy Growth Appoints David Manner as Managing Director of Storz & Bickel
select

News

Newsfilter
5.0
05-07Newsfilter
Canopy Growth Expands Softgel Product Line
  • Product Line Expansion: Canopy Growth and Spectrum Therapeutics have launched new 30 and 90-pack formats of Minor Cannabinoid softgels, aimed at enhancing patient convenience and accessibility, thereby strengthening market competitiveness.
  • Patient Demand Response: The introduction of these new products is based on strong performance feedback from existing 30-pack formats, indicating a pressing need for higher value and flexible dosing among patients, further driving innovation in the medical cannabis sector.
  • Daytime and Nighttime Formulations: The newly launched Clarity, Unwind, and Daily Relief softgels cater to daytime activities and nighttime relaxation, offering diverse dosing options designed to improve patient adherence and treatment efficacy.
  • Market Strategic Positioning: This expansion is not merely an increase in product quantity but also a proactive response to patient feedback, reflecting Canopy Growth's long-term strategic positioning in the medical cannabis market and its commitment to addressing patient needs.
stocktwits
2.0
05-01stocktwits
AKAN Stock Soars 300%, Set for Best Week Ever
  • Stock Surge: AKAN's stock has surged 300% this week, marking its best weekly performance ever, reflecting improved investor sentiment across cannabis stocks, particularly after the U.S. Justice Department moved state-regulated marijuana to Schedule III, significantly boosting optimism in the sector.
  • Micro Float Advantage: With a public float of only 534,420 shares following multiple reverse stock splits, AKAN's stock skyrocketed 1,700% in April, outperforming peers like Trulieve and Canopy Growth, highlighting the sensitivity of micro-float stocks to buying pressure during market rebounds.
  • Strategic Shift: AKAN is increasingly focusing on the Canadian and European markets while building a telecommunications infrastructure through its First Towers & Fiber unit in Mexico, which is expected to generate $2 million in contracted cash flow over the next decade, providing a hedge against the volatility typical in pure cannabis companies.
  • Market Sentiment High: Retail sentiment for AKAN on Stocktwits is extremely bullish, with message volumes surging 231,800% over the past month, indicating strong investor interest in the stock, despite potential short-term corrections, as traders remain optimistic about its future performance.
Newsfilter
8.5
04-30Newsfilter
Cannabis Edibles Market Experiences Rapid Growth
  • Market Size Projections: The global cannabis edibles market is expected to reach approximately $7.1 billion by 2025 and climb to around $16.6 billion by 2030, indicating a strong growth trajectory driven by consumer demand for cleaner, more discreet consumption methods.
  • Successful International Export: Herbal Dispatch has successfully completed its first export of medical cannabis gummies to Australia, generating approximately $350,000 in revenue, marking a significant milestone in the company's international growth strategy and reinforcing its position as a trusted supplier in the global medical cannabis market.
  • Product Diversification Strategy: Herbal Dispatch is actively expanding its gummies and edibles offerings domestically under the Chomp brand, responding to strong consumer demand across both medical and recreational channels, highlighting the company's focus on convenient, dose-controlled formats to drive long-term growth.
  • Emerging Investment Opportunities: With potential U.S. federal reform and the ongoing expansion of medical programs globally, the cannabis edibles market is positioned at the intersection of several powerful trends, likely capturing a larger market share and driving revenue diversification in high-growth categories.
stocktwits
2.0
04-30stocktwits
AKAN Stock Surges Following Marijuana Reclassification
  • Stock Performance: Since the marijuana reclassification, AKAN stock has significantly outperformed peers Tilray, Canopy Growth, and Aurora Cannabis, which have seen declines of 8%, 4%, and 8% respectively, while AKAN surged 32%.
  • Market Reaction: In the latest pre-market trading, AKAN shares surged 32%, marking its fourth-largest single-day gain this year, reflecting strong market confidence in its future growth potential.
  • Policy Impact: The U.S. Department of Justice's reclassification of medical marijuana as a less dangerous drug is expected to ease regulatory burdens on licensed operators, provide tax relief, and support research, driving AKAN's strong performance.
  • Retail Trader Sentiment: Over the past 30 days, message volume for AKAN on Stocktwits has skyrocketed by over 106,200%, indicating extremely bullish sentiment among retail investors, with many predicting the stock could reach triple digits.
Fool
2.0
04-27Fool
Canopy Growth Stock Rises on Marijuana Rescheduling News
  • Positive Market Reaction: The U.S. government's rescheduling of medical marijuana from Schedule I to Schedule III has driven Canopy Growth's stock up over 30% in the past month, despite only a 2% increase year-to-date in 2026.
  • Significant Market Cap Decline: Canopy Growth's market cap has plummeted from approximately $11 billion five years ago to around $500 million today, representing a staggering 95% decline, highlighting the company's poor performance and operational downsizing.
  • Substantial Financial Losses: While rescheduling may benefit the cannabis industry overall, Canopy Growth reported a loss of 327 million Canadian dollars over the past 12 months, indicating that investment risks remain high and investors should proceed with caution.
  • Uncertain Industry Outlook: Although rescheduling could lower tax burdens for multi-state operators in the U.S., Canopy Growth lacks a presence in the U.S. market and faces slow legalization processes, suggesting that investor optimism may be short-lived.
Fool
8.5
04-24Fool
Canopy Growth's 25% Stock Surge Masks Underlying Risks
  • Price Volatility Analysis: Canopy Growth's stock fluctuated from $0.857 to $1.38 over the past month, with a 25% increase that translates to only a $0.50 change, highlighting the high-risk nature of penny stocks.
  • Financial Improvement: The company has significantly reduced its debt, strengthening its financial position; however, this recapitalization required issuing new shares, which diluted existing shareholders amidst ongoing losses.
  • Acquisition to Expand Business: Canopy Growth recently agreed to acquire another company, extending its reach in the medical marijuana sector, but this also necessitated further share issuance, increasing dilution risk for shareholders.
  • Lack of Profitability: Despite the recent stock surge, Canopy Growth has not achieved sustainable profitability since 2017, with ongoing losses indicating high risk for investors, suggesting that most should avoid this penny stock for now.
Wall Street analysts forecast CGC stock price to rise
4 Analyst Rating
Wall Street analysts forecast CGC stock price to rise
1 Buy
2 Hold
1 Sell
Hold
Current: 0.000
sliders
Low
1.03
Averages
2.52
High
5.90
Current: 0.000
sliders
Low
1.03
Averages
2.52
High
5.90
Canaccord
Buy
initiated
$2
AI Analysis
2026-03-27
Reason
Canaccord
Price Target
$2
AI Analysis
2026-03-27
initiated
Buy
Reason
Canaccord initiated coverage of Canopy Growth with a Buy rating and C$2 price target. Canopy is a leading cannabis company producing, distributing, and selling a "diverse range" of cannabis and cannabis-related products in key, global adult-use and medical cannabis markets, the analyst tells investors in a research note. The firm says the company's pivot from an asset-light, third-party supply model to an asset-right, in-house supply model will improve its global competitive positioning.
Alliance Global
Aaron Grey
Neutral
downgrade
2026-02-06
Reason
Alliance Global
Aaron Grey
Price Target
2026-02-06
downgrade
Neutral
Reason
Alliance Global analyst Aaron Grey lowered the firm's price target on Canopy Growth to C$1.80 from C$2.50 and keeps a Neutral rating on the shares following the fiscal Q3 report. The firm reduced the stock's multiple to reflect the potential impact from changes to veteran reimbursement and uncertainty around its gross margins.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CGC
Unlock Now

Valuation Metrics

The current forward P/E ratio for Canopy Growth Corp (CGC.O) is 20.37, compared to its 5-year average forward P/E of -3.41. For a more detailed relative valuation and DCF analysis to assess Canopy Growth Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-3.41
Current PE
20.37
Overvalued PE
11.57
Undervalued PE
-18.38

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-280.02
Current EV/EBITDA
-15.78
Overvalued EV/EBITDA
444.21
Undervalued EV/EBITDA
-1004.25

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
4.17
Current PS
1.40
Overvalued PS
8.44
Undervalued PS
-0.09

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

how is cannibis securities doing today
Intellectia · 8 candidates
Market Cap: >= 100.00MPrice: >= $1.00Themes: The Cannabis IndustryMonthly Average Dollar Volume: >= 200,000
Ticker
Name
Market Cap$
top bottom
CGC logo
CGC
Canopy Growth Corp
511.04M
TLRY logo
TLRY
Tilray Brands Inc
803.02M
SNDL logo
SNDL
SNDL Inc
391.39M
VFF logo
VFF
Village Farms International Inc
328.97M
ACB logo
ACB
Aurora Cannabis Inc
201.89M
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.49B
list10 stocks up 5%
Intellectia · 371 candidates
Price Change Pct: >= $5.00
Ticker
Name
Market Cap$
top bottom
AGPU logo
AGPU
Axe Compute Inc
25.59M
ELPW logo
ELPW
eLong Power Holding Ltd
2.23M
TORO logo
TORO
Toro Corp
112.81M
NMAX logo
NMAX
Newsmax Inc
940.13M
BEEM logo
BEEM
Beam Global
32.13M
XNDU logo
XNDU
Xanadu Quantum Technologies Ltd
8.18B
Top stocks to buy between 1 and 2 dollors
Intellectia · 291 candidates
Region: USPrice: $1.00 - $2.00List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
SID logo
SID
Companhia Siderurgica Nacional SA
1.78B
IQ logo
IQ
iQIYI Inc
1.35B
GERN logo
GERN
Geron Corp
1.08B
AMC logo
AMC
AMC Entertainment Holdings Inc
938.30M
OPK logo
OPK
OPKO Health Inc
918.47M
LXRX logo
LXRX
Lexicon Pharmaceuticals Inc
779.57M
what are the cheapest
Intellectia · 146 candidates
Price: $0.10 - $5.00Rsi Category: moderateRelative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20One Day Predict Return: >= 0.0%Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
QNCX logo
QNCX
Quince Therapeutics Inc
10.20M
GPUS logo
GPUS
Hyperscale Data Inc
54.64M
BURU logo
BURU
NUBURU Inc
29.16M
PMNT logo
PMNT
Perfect Moment Ltd
13.69M
OPTT logo
OPTT
Ocean Power Technologies Inc
83.41M
GUTS logo
GUTS
Fractyl Health Inc
73.79M
top 5 penny stocks?
Intellectia · 91 candidates
Market Cap: 50.00M - 2.00BRegion: USPrice: $0.10 - $5.00List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Month Price Change Pct: $0.00 - $150.00Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
RXT logo
RXT
Rackspace Technology Inc
409.23M
KOS logo
KOS
Kosmos Energy Ltd
1.03B
IOVA logo
IOVA
Iovance Biotherapeutics Inc
1.14B
GERN logo
GERN
Geron Corp
1.20B
TRX logo
TRX
TRX Gold Corp
516.12M
AQST logo
AQST
Aquestive Therapeutics Inc
481.91M
Should I Buy cannabis stocks?
Intellectia · 9 candidates
Market Cap: >= 50.00MThemes: The Cannabis IndustryList Exchange: XNYS, XNASMonthly Average Dollar Volume: >= 100,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
4.06B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.29B
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
CGC logo
CGC
Canopy Growth Corp
440.50M
SNDL logo
SNDL
SNDL Inc
386.25M
cannabis
Intellectia · 8 candidates
Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryIs Optionable: TrueMonthly Average Dollar Volume: >= 200,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
4.06B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.29B
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
CGC logo
CGC
Canopy Growth Corp
440.50M
SNDL logo
SNDL
SNDL Inc
386.25M
stocks under $2 for day trade today
Intellectia · 158 candidates
Price: <= $2.00Volume: >= 500,000Price Change Pct: $-5.00 - $20.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
PHIO logo
PHIO
Phio Pharmaceuticals Corp
12.06M
PLUG logo
PLUG
Plug Power Inc
2.84B
BURU logo
BURU
NUBURU Inc
56.42M
TIRX logo
TIRX
Tian Ruixiang Holdings Ltd
10.04M
JTAI logo
JTAI
Jet.AI Inc
5.61M
BTBT logo
BTBT
Bit Digital Inc
563.19M
marijuana stocks
Intellectia · 8 candidates
Market Cap: >= 200.00MRegion: US, CanadaPrice: >= $1.00Themes: The Cannabis IndustryList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.70B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.41B
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M
CGC logo
CGC
Canopy Growth Corp
460.70M
SNDL logo
SNDL
SNDL Inc
406.85M
stocks to buy for 1.19 i only have $10
Intellectia · 105 candidates
Price: <= $1.19Weekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
ASST logo
ASST
Strive Inc
1.11B
UP logo
UP
Wheels Up Experience Inc
624.57M
CAN logo
CAN
Canaan Inc
498.64M
CGC logo
CGC
Canopy Growth Corp
460.70M
DVLT logo
DVLT
Datavault AI Inc
433.82M
BYND logo
BYND
Beyond Meat Inc
424.50M

Whales Holding CGC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Canopy Growth Corp (CGC) stock price today?

The current price of CGC is 1.11 USD — it has decreased -1.77

What is Canopy Growth Corp (CGC)'s business?

Canopy Growth Corporation is a cannabis company, which produces, distributes, and sells a diverse range of cannabis and cannabis-related products for both adult-use and medical purposes. The Company brands include tweed, DOJA, LivRelief Infused, Deep Space, Ace Valley, 7ACRES, Vert, Twd, Wana, Hiway and Canopy Medical. The LivRelief Infused is transdermal creams contain a delivery system designed to penetrate a range of cannabidiol (CBD) and tetrahydrocannabinol (THC). The Deep Space offers beverages and gummies, containing the THC potency available in the Canadian market. The Ace Valley is a cannabis brand focused on ready-to-enjoy beverages. The 7ACRES offers products that are crafted by cannabis enthusiasts. The Wana gummies are created with a handcrafted recipe made with pectin, not gelatin, creating a gluten-free shelf-stable recipe that doesn’t melt. Its Canopy Medical is a pharmaceutical manufacturer for the production, import and release of medical cannabis products in Germany.

What is the price predicton of CGC Stock?

Wall Street analysts forecast CGC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CGC is2.52 USD with a low forecast of 1.03 USD and a high forecast of 5.90 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Canopy Growth Corp (CGC)'s revenue for the last quarter?

Canopy Growth Corp revenue for the last quarter amounts to 74.54M USD, decreased -0.29

What is Canopy Growth Corp (CGC)'s earnings per share (EPS) for the last quarter?

Canopy Growth Corp. EPS for the last quarter amounts to -0.18 USD, decreased -83.78

How many employees does Canopy Growth Corp (CGC). have?

Canopy Growth Corp (CGC) has 960 emplpoyees as of May 09 2026.

What is Canopy Growth Corp (CGC) market cap?

Today CGC has the market capitalization of 497.59M USD.